From the Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
J Am Acad Orthop Surg. 2021 Oct 15;29(20):e1013-e1024. doi: 10.5435/JAAOS-D-20-00613.
The C-reactive protein/albumin ratio (CAR) is a marker of inflammation that has been associated with negative outcomes in the general surgery. This study investigates the potential association of preoperative CAR with postoperative complications and readmission rates in the treatment of patients with single-stage revision total joint arthroplasty for periprosthetic joint infection.
A total of 213 consecutive patients who had undergone single-stage revision for total joint arthroplasty with the preoperative diagnosis of periprosthetic joint infection and preoperative C-reactive protein and albumin values were included. The area under receiver operating characteristic curves was calculated to evaluate the CAR as a predictive value for the complications.
Significant differences between the mean CAR were found for patients with 30- and 60-day readmissions and reinfection (P < 0.01). CAR combined with serum and synovial fluid markers demonstrated significantly higher sensitivities and specificities for the prediction of 30-day (total knee arthroplasty [TKA]: 94%; 95%; total hip arthroplasty [THA]: 91%; 96%) and 60-day readmissions (THA: 94%; 95%; TKA: 92%; 96%) and reinfections (TKA: 94%; 95%; THA: 87%; 96%), when compared with only serum and synovial fluid markers combined (83%; 84%; 85%; 87%; 85%; 88%; P <0.01).
High preoperative CAR, when combined with serum and synovial fluid markers, was associated with increased risk of reinfection and 30- and 60-day readmissions, suggesting that preoperative CAR is a clinically useful predictor for postoperative complications in patients with periprosthetic hip and knee joint infections.
C 反应蛋白/白蛋白比值(CAR)是炎症的标志物,与普通外科的不良结局相关。本研究旨在探讨术前 CAR 与一期翻修治疗假体周围关节感染的全关节置换术后并发症和再入院率的潜在相关性。
共纳入 213 例因假体周围关节感染而行一期翻修全关节置换术的连续患者,术前检测 C 反应蛋白和白蛋白值。计算受试者工作特征曲线下面积以评估 CAR 对并发症的预测价值。
30 天和 60 天再入院和再感染患者的平均 CAR 存在显著差异(P<0.01)。CAR 联合血清和滑膜液标志物对 30 天(全膝关节置换术[TKA]:94%;95%;全髋关节置换术[THA]:91%;96%)和 60 天再入院(THA:94%;95%;TKA:92%;96%)和再感染(TKA:94%;95%;THA:87%;96%)的预测具有更高的敏感性和特异性,与仅联合血清和滑膜液标志物相比(83%;84%;85%;87%;85%;88%;P<0.01)。
术前高 CAR 与血清和滑膜液标志物联合时,与再感染和 30 天和 60 天再入院风险增加相关,表明术前 CAR 是假体周围髋关节和膝关节感染患者术后并发症的一种有用的临床预测指标。